Endoscopic Third Ventriculostomy (ETV): Procedure, Candidacy, and Recovery

When a patient is diagnosed with hydrocephalus, the most familiar word in the treatment conversation is “shunt.” Ventriculoperitoneal (VP) shunts have been the standard treatment for hydrocephalus for decades, but they come with a known limitation: they are mechanical devices that can fail, malfunction, or become infected over the lifetime of the patient. For appropriately selected patients with obstructive hydrocephalus, endoscopic third ventriculostomy (ETV) offers an alternative that relies on the body’s own CSF circulation rather than on an implanted device.

What Is Endoscopic Third Ventriculostomy (ETV)?

Endoscopic third ventriculostomy (ETV) is a minimally invasive neurosurgical procedure that treats hydrocephalus by creating a small opening in the floor of the third ventricle, one of the fluid-filled chambers within the brain. This opening allows cerebrospinal fluid (CSF) to bypass the obstruction that is causing hydrocephalus and flow directly into the spaces surrounding the brain, where it can be reabsorbed normally.

ETV essentially creates an internal bypass for CSF, restoring circulation without implanting a device. When successful, ETV can eliminate the need for a VP shunt entirely, or treat shunt failure without replacing the shunt.

Understanding Hydrocephalus: Why CSF Flow Matters

Cerebrospinal fluid is produced continuously within the brain’s ventricular system and normally circulates around the brain and spinal cord before being reabsorbed. When this circulation is blocked, fluid accumulates, the ventricles enlarge, and pressure builds within the skull, a condition called hydrocephalus.

Obstructive hydrocephalus (also called non-communicating hydrocephalus) occurs when the blockage is within the ventricular system itself, most commonly at the cerebral aqueduct, the narrow channel connecting the third and fourth ventricles. Aqueductal stenosis (narrowing of the aqueduct) is the most common cause of obstructive hydrocephalus in adults and older children, and it is the most favorable indication for ETV.

Communicating hydrocephalus, in which CSF circulates freely but is not adequately reabsorbed, is not effectively treated by ETV and remains an indication for shunt placement.

Who is a Candidate for ETV?

ETV is most effective for patients with obstructive (non-communicating) hydrocephalus. Specific favorable indications include:

• Aqueductal stenosis: Narrowing of the cerebral aqueduct, whether congenital, acquired, or secondary to tumor, infection, or hemorrhage
• Third ventricular obstruction: Masses (such as pineal region tumors, tectal gliomas, or colloid cysts) obstructing CSF flow at or near the aqueduct
• Shunt failure or shunt dependency: ETV can be used to wean appropriately selected patients off dysfunctional shunts or to treat recurrent shunt malfunction
• Post-infectious or post-hemorrhagic hydrocephalus: Selected cases may benefit, though success rates are lower

ETV is generally NOT the first-line treatment for communicating hydrocephalus, normal pressure hydrocephalus (NPH), or hydrocephalus in very young infants (typically under 6 months), where the success rate is significantly lower.

ETV Success Score (ETVSS): Neurosurgeons use a validated scoring tool, the ETV Success Score, to estimate the probability of ETV success for individual patients based on age, etiology of hydrocephalus, and prior shunt history. A higher ETV Success Score (above 70%) generally favors ETV as the primary approach. Your NJBS neurosurgeon will discuss your individual ETV Success Score as part of the surgical planning process.

Before the ETV Procedure

Preparation for ETV at NJBS includes:

1. Pre-operative imaging: High-resolution MRI of the brain with specific sequences (such as CISS or FIESTA) to evaluate ventricular anatomy, the thickness and structure of the floor of the third ventricle, and the patency of the cerebral aqueduct.
2. CSF flow studies: In selected patients, phase-contrast MRI is used to assess CSF dynamics.
3. Medical evaluation: Assessment of overall health, medications, and any pre-operative optimization needed.
4. Discussion of alternatives: Your NJBS neurosurgeon will review ETV versus VP shunt as options and help you understand why ETV is being recommended for your specific situation.
5. Anesthesia consultation: ETV is performed under general anesthesia.

During the ETV Procedure

ETV is performed endoscopically, using a thin, flexible or rigid neuroendoscope, through a single small entry point in the skull. The procedure proceeds as follows:

1. Anesthesia and positioning: The patient is positioned supine (face up) and placed under general anesthesia. The head is secured in a neutral or slightly flexed position.
2. Burr hole creation: A single small hole (approximately 1 cm in diameter) is made in the skull, typically on the right side, just in front of the coronal suture. This is the only incision required.
3. Endoscope insertion: The rigid neuroendoscope is introduced through the burr hole and navigated through the right lateral ventricle under direct visualization.
4. Ventricular navigation: The endoscope is guided through the interventricular foramen (foramen of Monro) into the third ventricle. The surgeon directly visualizes the ventricular anatomy in real time via a camera on the endoscope.
5. Ventriculostomy: A small perforation is created in the thinned floor of the third ventricle (the tuber cinereum) using a blunt probe or balloon catheter. This opening, the ventriculostomy, allows CSF to flow from the third ventricle directly into the prepontine cistern (a natural CSF space at the base of the brain), bypassing the obstruction.
6. Confirmation: The surgeon confirms that the stoma is patent (open) and that CSF is flowing freely through it. Additional procedures (such as septum pellucidotomy or aqueductoplasty) may be performed endoscopically at the same time if indicated.
7. Closure: The endoscope is withdrawn, and the burr hole site is closed. Total operative time is typically 30 to 90 minutes.

After the ETV Procedure and Recovery

Hospital Stay: ETV is typically followed by an overnight hospital stay, with close neurological monitoring. Most patients are discharged within 24 to 48 hours if they are neurologically stable and have no signs of early failure.

Recovery: Most patients recover rapidly. Headache and mild fatigue are common in the first several days. Symptoms of hydrocephalus, including headache, visual changes, and cognitive slowing, begin to improve within days to weeks if the ETV is functioning.

Activity Restrictions:

• Heavy lifting and strenuous activity are restricted for 2 to 4 weeks
• Return to desk work: typically within 1 to 2 weeks for most adults
• Driving: typically restricted for 2 to 4 weeks (individualized guidance from your surgeon)

Follow-Up Imaging: MRI or CT of the brain is obtained at approximately 6 weeks post-operatively to confirm that the ventriculostomy is patent and that ventricular size has stabilized or decreased.

Monitoring for ETV failure: ETV can fail, most commonly within the first 6 months after surgery. Signs of ETV failure are the same as hydrocephalus symptoms: worsening headache, nausea, vomiting, visual changes, or cognitive decline. Patients are instructed to seek evaluation immediately if these symptoms recur, as ETV failure can be sudden.

Long-Term Outcomes: In appropriately selected adult patients with obstructive hydrocephalus, ETV achieves long-term success (avoiding the need for a shunt) in approximately 60% to 85% of cases, depending on etiology and ETV Success Score. Patients who fail ETV can undergo shunt placement without compromise to subsequent outcomes.

Risks and Complications

ETV is a minimally invasive procedure, but serious risks exist:

• Failure to achieve or maintain adequate CSF drainage: The most common complication. Requires shunt placement if ETV fails.
• Hemorrhage: The endoscope passes near vascular structures. Bleeding is rare but potentially serious.
• Injury to surrounding structures: The fornix, basilar artery, and cranial nerves are adjacent to the operative field. Skilled endoscopic technique minimizes these risks.
• Infection / meningitis: Uncommon; treated with antibiotics. CSF leakage from the operative site is rare given the minimally invasive approach.
• Hypothalamic or pituitary injury: Very rare; may cause hormonal abnormalities.
• Memory disturbance: Injury to the fornix (memory pathway) is a known risk of ventricular endoscopy; meticulous technique minimizes this.

The NJBS team discusses all procedure-specific risks with patients and families during the pre-operative consultation.

FREQUENTLY ASKED QUESTIONS

SCHEDULE A CONSULTATION

NJBS serves patients across northern New Jersey and the greater tri-state area, with offices in Paramus, Hackensack, Montclair, Montvale, Annandale, and Englewood.  No referral is required to schedule a consultation.

Schedule a consultation or request a second opinion today.